Get started Log in

4974 — Takara Bio Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Market Cap
¥138bn
Enterprise Value
¥128bn
Revenue
¥40bn

Table: Takara Bio - 9-MTH group results
09/02/2023 06:00
Brief: Takara Bio To Build A New Factory In Its Shiga Hq Compound To Boost Production Of Covid Vaccines - Nikkei
05/12/2022 09:05
Brief: Takara Bio Inc - To End Joint Development And Sales Contract Of Gene Therapy Drug Ny-Eso-1・Sitcr With Otsuka Pharmaceutical
10/11/2022 06:47
Table: Takara Bio - 6-MTH group results
10/11/2022 06:30
Table: Takara Bio Inc. -2022 6-month group forecast
25/10/2022 07:00
Brief: Takara Bio Usa, Inc. And Bioexcel Diagnostics Partner For Development Of Wide-Coverage Infectious Disease Detection Panels
17/10/2022 13:26
Table: Takara Bio -Q1 group results
04/08/2022 07:00
Table: Takara Bio -2021/22 group results
12/05/2022 07:00
Table: Takara Bio -2021/22 parent results
12/05/2022 07:00
Brief: Takara Bio Inc - European Patent Office Has Reviewed And Confirmed Validity Of Tbusa's Granted European Patent Ep 3105325
15/02/2022 13:11
Table: Takara Bio - 9-MTH group results
10/02/2022 06:00
Table: Takara Bio - 6-MTH group results
09/11/2021 06:00
Brief: Japan's Takara Bio To Manufacture Mrna Vaccines On Contract - Nikkei
03/11/2021 18:28
Table: Takara Bio Inc. -2021 6-month group forecast
21/10/2021 07:00
Table: Takara Bio -Q1 group results
06/08/2021 07:01
Table: Takara Bio -Q1 group results
03/08/2021 07:00
Table: Takara Bio -2020/21 group results
13/05/2021 07:00
Table: Takara Bio -2020/21 parent results
13/05/2021 07:00
Table: Takara Bio - 9-MTH group results
10/02/2021 06:00
Table: Takara Bio - 6-MTH group results
10/11/2020 06:00